GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Days Sales Outstanding

Bioservo Technologies AB (OSTO:BIOS) Days Sales Outstanding : 46.02 (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Bioservo Technologies AB Days Sales Outstanding?

Bioservo Technologies AB's average Accounts Receivable for the three months ended in Sep. 2023 was kr2.10 Mil. Bioservo Technologies AB's Revenue for the three months ended in Sep. 2023 was kr4.16 Mil. Hence, Bioservo Technologies AB's Days Sales Outstanding for the three months ended in Sep. 2023 was 46.02.

The historical rank and industry rank for Bioservo Technologies AB's Days Sales Outstanding or its related term are showing as below:

OSTO:BIOS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.33   Med: 102.01   Max: 139.69
Current: 104.33

During the past 8 years, Bioservo Technologies AB's highest Days Sales Outstanding was 139.69. The lowest was 16.33. And the median was 102.01.

OSTO:BIOS's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 65.105 vs OSTO:BIOS: 104.33

Bioservo Technologies AB's Days Sales Outstanding declined from Sep. 2022 (117.62) to Sep. 2023 (46.02).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Bioservo Technologies AB Days Sales Outstanding Historical Data

The historical data trend for Bioservo Technologies AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioservo Technologies AB Days Sales Outstanding Chart

Bioservo Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial 135.07 122.62 61.99 53.08 131.48

Bioservo Technologies AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.62 286.88 93.51 193.33 46.02

Competitive Comparison of Bioservo Technologies AB's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Bioservo Technologies AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioservo Technologies AB's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioservo Technologies AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bioservo Technologies AB's Days Sales Outstanding falls into.


Bioservo Technologies AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bioservo Technologies AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (1.43 + 5.517) / 2 ) / 9.643*365
=3.4735 / 9.643*365
=131.48

Bioservo Technologies AB's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding (Q: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (1.127 + 3.066) / 2 ) / 4.157*365 / 4
=2.0965 / 4.157*365 / 4
=46.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioservo Technologies AB  (OSTO:BIOS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Bioservo Technologies AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bioservo Technologies AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioservo Technologies AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Days Sales Outstanding
Comparable Companies
XSAT:MEDIMI XSAT:ODIN XSAT:AUDNTS OSTO:S2M XSAT:EURI B XSAT:BIBB NGM:PRLD OSTO:IZAFE B OSTO:ORTI A ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX
Traded in Other Exchanges
N/A
Address
Torshamnsgatan 35, Kista, SWE, 164 40
Website
https://www.bioservo.com
Bioservo Technologies AB is a Sweden based wearable muscle strengthening systems provider company. It develops wearable technologies based on bionic soft robotics. The company offers SEM Gloves, a grip strengthening aid designed for people with impaired hand function or grip-intensive occupations.